Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
CRGX is expected to report earnings to fall 26.55% to -129 cents per share on August 12
Q2'25
Est.
$-1.30
Q1'25
Missed
by $0.60
Q4'24
Beat
by $0.73
Q3'24
Beat
by $0.73
Q2'24
Beat
by $0.39
The last earnings report on May 14 showed earnings per share of -176 cents, missing the estimate of -116 cents. With 157.19K shares outstanding, the current market capitalization sits at 190.45M.